Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | A607E |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TSC2 A607E does not lie within any known functional domains of the Tsc2 protein (UniProt.org). A607E results in the loss of repression of Mtorc1 as indicated by assays that demonstrate increased phosphorylation of S6k in cultured cells (PMID: 18854862). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 A607E |
Transcript | NM_000548.5 |
gDNA | chr16:g.2070559C>A |
cDNA | c.1820C>A |
Protein | p.A607E |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001077183.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522637.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522637.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406686.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406688.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_005255529.4 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406663.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_017023615.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001318831.2 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406698.1 | chr16:g.2080321_2080322delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406683.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406687.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406684.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406680.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
XM_011522639.2 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406685.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406682.1 | chr16:g.2074264_2074265delCCinsAG | c.1820_1821delCCinsAG | p.A607E | RefSeq | GRCh38/hg38 |
NM_001406664.1 | chr16:g.2070559C>A | c.1820C>A | p.A607E | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|